Get the Stockscreener App
0.701
4.91%
0.0328
Nautilus Biotechnology Inc Stock (NAUT) Forecast
The Nautilus Biotechnology Inc (NAUT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.4849, representing a +111.83% increase from the current price of $0.701. The highest analyst price target is $1.4105, and the lowest is $1.5593.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NAUT Price Target
Average 0.9477
(+35.19% Upside)
Is Nautilus Biotechnology Inc (NAUT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.72 | Neutral |
| STOCH(9,6) | 10.01 | Buy |
| STOCHRSI(14) | 2.0767 | Buy |
| MACD(12,26) | -0.0161 | Sell |
| ADX(14) | 17.31 | Neutral |
| William %R | -93.27 | Buy |
| CCI(14) | -125.92 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7127
Sell
|
0.7109
Sell
|
| MA20 |
0.7369
Sell
|
0.726
Sell
|
| MA50 |
0.7418
Sell
|
0.7521
Sell
|
| MA100 |
0.7525
Sell
|
0.8757
Sell
|
| MA200 |
1.2745
Sell
|
1.2384
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NAUT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on NAUT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.72 indicates that NAUT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.01 indicates that NAUT is oversold. This indicates that NAUT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.0767 indicates that NAUT is oversold. This suggests that NAUT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.31 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -125.92 indicates that NAUT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NAUT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nautilus Biotechnology Inc financial reports and earnings history, Nautilus Biotechnology Inc (NAUT) stock could reach $2.1733 by 2030, $21.40 by 2040 and $34.95 by 2050. See the projected annual prices until 2050 of the Nautilus Biotechnology Inc stock below:
- Nautilus Biotechnology Inc (NAUT) is expected to reach an average price of $12.19 in 2035, with a high prediction of $12.41 and a low estimate of $12.35. This indicates an $1,639% rise from the last recorded price of $0.701.
- Nautilus Biotechnology Inc (NAUT) stock is projected to chart a bullish course in 2040, with an average price target of $21.52, representing an $2,970% surge from its current level. The forecast ranges from a conservative $6.4064 to a sky-high $21.40.
- Our analysts predict Nautilus Biotechnology Inc (NAUT) to jump 2,569% by 2045, soaring from $19.03 to an average price of $18.71, potentially reaching $19.38. While $19.03 is the low estimate, the potential upside is significant.
- Nautilus Biotechnology Inc (NAUT) stock is expected to climb by 2050, reaching an average of $34.58, a $4,833% jump from its current level. However, a wide range of estimates exists, with high and low targets of $34.95 and $34.76, respectively, highlighting the market's uncertainty.
Nautilus Biotechnology Inc Stock (NAUT) Year by Year Forecast
Nautilus Biotechnology Inc Stock (NAUT) Price Forecast for 2025
Nautilus Biotechnology Inc Stock (NAUT) is expected to reach an average price of $0.8243 in 2025, with a high prediction of $1.5981 and a low estimate of $0.0506. This indicates an +17.59% rise from the last recorded price of $0.701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $1.1127 | $1.5593 | $1.4105 | +58.73% |
| October, 2025 | $1.6285 | $1.1539 | $1.5085 | +132.31% |
| November, 2025 | $1.7831 | $1.6008 | $1.5981 | +154.36% |
| December, 2025 | $1.4188 | $1.4388 | $1.4454 | +102.40% |
Nautilus Biotechnology Inc Stock (NAUT) Price Forecast for 2026
The predicted value for Nautilus Biotechnology Inc (NAUT) in 2026 is set at an average of $0.9477. Estimates vary from a peak of $1.8825 to a trough of $0.0129, indicating an +35.19% surge from the present price of $0.701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.1634 | $1.2034 | $1.21 | +65.96% |
| February, 2026 | $0.898 | $0.978 | $0.9269 | +28.10% |
| March, 2026 | $0.2426 | $0.5226 | $0.7892 | -65.39% |
| April, 2026 | $0.5583 | $0.3949 | $0.2322 | -20.35% |
| May, 2026 | $0.0171 | $0.0129 | $0.3695 | -97.57% |
| June, 2026 | $0.9025 | $0.1362 | $1.8825 | +28.74% |
| July, 2026 | $0.3967 | $0.3013 | $1.2702 | -43.41% |
| August, 2026 | $0.3121 | $0.2333 | $0.8444 | -55.47% |
| September, 2026 | $1.4364 | $0.251 | $1.4964 | +104.90% |
| October, 2026 | $0.4318 | $0.3918 | $1.4252 | -38.40% |
| November, 2026 | $0.5172 | $0.0717 | $0.6506 | -26.22% |
| December, 2026 | $0.6714 | $0.066 | $0.9749 | -4.22% |
Nautilus Biotechnology Inc Stock (NAUT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nautilus Biotechnology Inc (NAUT) is $2.3464, with a high forecast of $4.2508 and a low forecast of $0.4419. This indicates an +234.72% increase from the last price of $0.701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.8068 | $0.5303 | $1.2715 | +15.10% |
| February, 2027 | $0.8823 | $0.7157 | $1.1045 | +25.86% |
| March, 2027 | $0.7965 | $0.5088 | $1.0677 | +13.62% |
| April, 2027 | $0.6219 | $0.4419 | $1.1231 | -11.28% |
| May, 2027 | $0.6073 | $0.5873 | $1.1896 | -13.36% |
| June, 2027 | $2.08 | $0.4662 | $1.96 | +196.72% |
| July, 2027 | $1.8792 | $1.8069 | $1.5869 | +168.07% |
| August, 2027 | $3.2884 | $2.4195 | $2.7265 | +369.10% |
| September, 2027 | $3.8999 | $3.3707 | $3.6865 | +456.33% |
| October, 2027 | $4.2191 | $3.8922 | $4.0091 | +501.86% |
| November, 2027 | $3.8983 | $4.146 | $4.0964 | +456.10% |
| December, 2027 | $4.7697 | $3.6929 | $4.2508 | +580.42% |
Nautilus Biotechnology Inc Stock (NAUT) Price Forecast for 2028
In 2028, Nautilus Biotechnology Inc (NAUT) is projected to reach an average price of $4.5045, with a high projection of $5.1071 and a low estimate of $3.9019. This indicates an +542.58% rise from the last price of $0.701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.5189 | $4.6989 | $4.6287 | +544.64% |
| February, 2028 | $4.9381 | $4.7158 | $4.6135 | +604.44% |
| March, 2028 | $3.7496 | $3.9796 | $4.4204 | +434.90% |
| April, 2028 | $3.4288 | $3.9019 | $4.0365 | +389.13% |
| May, 2028 | $4.2503 | $4.0811 | $4.0803 | +506.32% |
| June, 2028 | $4.7395 | $4.2726 | $4.7072 | +576.10% |
| July, 2028 | $4.8787 | $4.9987 | $4.9441 | +595.96% |
| August, 2028 | $5.2102 | $4.6879 | $4.606 | +643.25% |
| September, 2028 | $4.9994 | $5.1694 | $5.1071 | +613.18% |
| October, 2028 | $5.1086 | $5.1186 | $4.919 | +628.75% |
| November, 2028 | $4.85 | $4.6377 | $4.951 | +591.88% |
| December, 2028 | $4.9692 | $4.8923 | $4.9392 | +608.88% |
Nautilus Biotechnology Inc Stock (NAUT) Price Forecast for 2029
The 2029 price forecast for Nautilus Biotechnology Inc Stock (NAUT) is $3.3292 on average, with a high prediction of $4.9311 and a low estimate of $1.7272. This represents an +374.92% increase from the previous price of $0.701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.7907 | $4.9715 | $4.9311 | +583.41% |
| February, 2029 | $4.4499 | $4.6776 | $4.7171 | +534.80% |
| March, 2029 | $4.0591 | $4.3291 | $4.3883 | +479.05% |
| April, 2029 | $3.9183 | $4.066 | $4.0414 | +458.96% |
| May, 2029 | $3.1198 | $3.3698 | $3.7606 | +345.05% |
| June, 2029 | $3.309 | $3.4421 | $3.269 | +372.04% |
| July, 2029 | $2.8682 | $2.8559 | $3.2113 | +309.15% |
| August, 2029 | $1.9997 | $1.9851 | $2.3105 | +185.26% |
| September, 2029 | $2.0189 | $2.072 | $1.9866 | +188.00% |
| October, 2029 | $1.8903 | $2.1703 | $2.0258 | +169.66% |
| November, 2029 | $1.7795 | $1.7272 | $1.6126 | +153.86% |
| December, 2029 | $2.4687 | $1.9218 | $1.7587 | +252.17% |
Nautilus Biotechnology Inc Stock (NAUT) Price Forecast for 2030
Nautilus Biotechnology Inc Stock (NAUT) is expected to reach an average price of $4.8308 in 2030, with a high forecast of $8.617 and a low forecast of $1.0446. This signifies an +589.13% surge from the last price of $0.701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5702 | $2.1102 | $2.1733 | +124.00% |
| February, 2030 | $1.4394 | $1.7094 | $1.5025 | +105.34% |
| March, 2030 | $1.2786 | $1.3863 | $1.1086 | +82.40% |
| April, 2030 | $1.3978 | $1.2295 | $1.1632 | +99.40% |
| May, 2030 | $1.2993 | $1.3093 | $1.2324 | +85.35% |
| June, 2030 | $1.1885 | $1.3185 | $1.1616 | +69.54% |
| July, 2030 | $1.16 | $1.1431 | $1.05 | +65.47% |
| August, 2030 | $7.1434 | $1.0446 | $6.82 | +919.04% |
| September, 2030 | $7.1572 | $6.6103 | $6.3903 | +921.00% |
| October, 2030 | $8.3645 | $7.4807 | $7.841 | +1,093% |
| November, 2030 | $8.1883 | $8.4883 | $8.3014 | +1,068% |
| December, 2030 | $8.712 | $8.5417 | $8.617 | +1,143% |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):